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A B S T R A C T
Background
Fibroids are the most common benign tumours of the female genital tract and are associated with numerous clinical problems including
a possible negative impact on fertility. In women requesting preservation of fertility, fibroids can be surgically removed (myomectomy)
by laparotomy, laparoscopically or hysteroscopically depending on the size, site and type of fibroid. Myomectomy is however a procedure
that is not without risk and can result in serious complications. It is therefore essential to determine whether such a procedure can result
in an improvement in fertility and, if so, to then determine the ideal surgical approach.
Objectives
To examine the eAect of myomectomy on fertility outcomes and to compare diAerent surgical approaches.
Search methods
We searched the Cochrane Gynaecology and Fertility Group (CGFG) Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL,
Epistemonikos database, World Health Organization (WHO) International Clinical Trials Registry Platform search portal, Database of
Abstracts of Reviews of EAects (DARE), LILACS, conference abstracts on the ISI Web of Knowledge, OpenSigle for grey literature from Europe,
and reference list of relevant papers. The final search was in February 2019.
Selection criteria
Randomised controlled trials (RCTs) examining the eAect of myomectomy compared to no intervention or where diAerent surgical
approaches are compared regarding the eAect on fertility outcomes in a group of infertile women suAering from uterine fibroids.
Data collection and analysis
Data collection and analysis were conducted in accordance with the procedure suggested in the Cochrane Handbook for Systematic Reviews
of Interventions.
Main results
This review included four RCTs with 442 participants. The evidence was very low-quality with the main limitations being due to serious
imprecision, inconsistency and indirectness.
Myomectomy versus no intervention
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One study examined the eAect of myomectomy compared to no intervention on reproductive outcomes. We are uncertain whether
myomectomy improves clinical pregnancy rate for intramural (odds ratio (OR) 1.88, 95% confidence interval (CI) 0.57 to 6.14; 45
participants; one study; very low-quality evidence), submucous (OR 2.04, 95% CI 0.62 to 6.66; 52 participants; one study; very low-quality
evidence), intramural/subserous (OR 2.00, 95% CI 0.40 to 10.09; 31 participants; one study; very low-quality evidence) or intramural/
submucous fibroids (OR 3.24, 95% CI 0.72 to 14.57; 42 participants; one study; very low-quality evidence). Similarly, we are uncertain
whether myomectomy reduces miscarriage rate for intramural fibroids (OR 1.33, 95% CI 0.26 to 6.78; 45 participants; one study; very low-
quality evidence), submucous fibroids (OR 1.27, 95% CI 0.27 to 5.97; 52 participants; one study; very low-quality evidence), intramural/
subserous fibroids (OR 0.80, 95% CI 0.10 to 6.54; 31 participants; one study; very low-quality evidence) or intramural/submucous fibroids
(OR 2.00, 95% CI 0.32 to 12.33; 42 participants; one study; very low-quality evidence). This study did not report on live birth, preterm
delivery, ongoing pregnancy or caesarean section rate.
Laparoscopic myomectomy versus myomectomy by laparotomy or mini-laparotomy
Two studies compared laparoscopic myomectomy to myomectomy at laparotomy or mini-laparotomy. We are uncertain whether
laparoscopic myomectomy compared to laparotomy or mini-laparotomy improves live birth rate (OR 0.80, 95% CI 0.42 to 1.50; 177
participants; two studies; I2 = 0%; very low-quality evidence), preterm delivery rate (OR 0.70, 95% CI 0.11 to 4.29; participants = 177; two
studies; I2 = 0%, very low-quality evidence), clinical pregnancy rate (OR 0.96, 95% CI 0.52 to 1.78; 177 participants; two studies; I2 = 0%,
very low-quality evidence), ongoing pregnancy rate (OR 1.61, 95% CI 0.26 to 10.04; 115 participants; one study; very low-quality evidence),
miscarriage rate (OR 1.25, 95% CI 0.40 to 3.89; participants = 177; two studies; I2 = 0%, very low-quality evidence), or caesarean section rate
(OR 0.69, 95% CI 0.34 to 1.39; participants = 177; two studies; I2 = 21%, very low-quality evidence).
Monopolar resectoscope versus bipolar resectoscope
One study evaluated the use of two electrosurgical systems during hysteroscopic myomectomy. We are uncertain whether bipolar
resectoscope use compared to monopolar resectoscope use improves live birth/ongoing pregnancy rate (OR 0.86, 95% CI 0.30 to 2.50; 68
participants; one study, very low-quality evidence), clinical pregnancy rate (OR 0.88, 95% CI 0.33 to 2.36; 68 participants; one study; very
low-quality evidence), or miscarriage rate (OR 1.00, 95% CI 0.19 to 5.34; participants = 68; one study; very low-quality evidence). This study
did not report on preterm delivery or caesarean section rate.
Authors' conclusions
There is limited evidence to determine the role of myomectomy for infertility in women with fibroids as only one trial compared
myomectomy with no myomectomy. If the decision is made to have a myomectomy, the current evidence does not indicate a superior
method (laparoscopy, laparotomy or diAerent electrosurgical systems) to improve rates of live birth, preterm delivery, clinical pregnancy,
ongoing pregnancy, miscarriage, or caesarean section. Furthermore, the existing evidence needs to be viewed with caution due to the
small number of events, minimal number of studies and very low-quality evidence.
P L A I N   L A N G U A G E   S U M M A R Y
Does surgical removal of fibroids improve fertility outcomes?
Review question
Cochrane authors reviewed the evidence about the eAect on fertility with the surgical removal of fibroids in infertile women.
Background
Fibroids are the most common benign tumours of the female genital tract and commonly aAect women of reproductive age. Fibroids occur
in diAerent parts of the womb and can vary in size and shape. Fibroids can lead to a variety of symptoms including heavy periods, pain,
diAiculty to conceive, or problems with pregnancy such as miscarriage and premature labour. In women wishing to preserve their fertility,
it is possible to remove the fibroid while preserving the womb, an operation known as myomectomy. This procedure can be performed
by laparotomy (open abdominal surgery), laparoscopic surgery (a key-hole through the abdomen) or hysteroscopic surgery (a key-hole
through the neck of the womb) depending on the site and size of the fibroid. This review aimed to answer two questions. Firstly, whether
myomectomy led to an improvement in fertility; and secondly, if the procedure is beneficial, what is the ideal surgical approach?
Study characteristics
This review included four studies with 442 participants. One study compared myomectomy to no treatment. The remaining three studies
compared diAerent surgical methods of performing a myomectomy. The evidence is current to February 2019.
Key results
One study examined the eAect of myomectomy compared to no treatment. Results found insuAicient evidence to determine a diAerence
between treatment options for clinical pregnancy rate or miscarriage rate. This study did not report on live birth, preterm delivery,
ongoing pregnancy or caesarean section rate. Regarding the best surgical approach, three studies were identified. Two studies compared
Surgical treatment of fibroids for subfertility (Review)
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myomectomy by mini-laparotomy or laparotomy to laparoscopic myomectomy and found insuAicient evidence to determine a diAerence
for live birth, preterm delivery, clinical pregnancy, miscarriage, caesarean section and ongoing pregnancy rate. The third study compared
use of diAerent surgical equipment during hysteroscopic myomectomy and found insuAicient evidence to determine a diAerence for live
birth/ongoing pregnancy rate, clinical pregnancy rate and miscarriage rate. This study did not report on caesarean section or preterm
delivery rate. It is clear that more studies are needed before a consensus can be reached on the role of myomectomy for infertility.
Quality of evidence
The evidence was very low quality. There are some concerns regarding how the data were analysed and therefore the evidence cannot be
considered to be conclusive until further studies are available.
Surgical treatment of fibroids for subfertility (Review)

































































S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Myomectomy compared to no treatment for fibroids for infertility
Myomectomy compared to no treatment for fibroids for infertility





















Live birth rate No study data available
Preterm delivery
rate
No study data available
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No study data available
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI). CI: Confidence interval; OR: Odds ratio; RCT: randomised controlled trial.
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
a Downgraded two levels for indirectness; population sampled limited (single fibroid of max. 4 cm diameter); outcomes assessed could have included late birth outcome
b Downgraded one level for imprecision; no sample size calculation, there is only one study and small number of events
 
 
Summary of findings 2.   Laparoscopic myomectomy compared to myomectomy by laparotomy or mini-laparotomy for fibroids for infertility
Laparoscopic myomectomy compared to myomectomy by laparotomy or mini-laparotomy for fibroids for infertility
Patient or population:fibroids for infertility
Setting: tertiary care 
Intervention: laparoscopic myomectomy
Comparison: myomectomy by laparotomy or mini-laparotomy










































































































































Live birth rate 36.3% 31.4%
(19.3 to 46)
5.0% fewer

















































VERY LOW a, b, c, d
 
Miscarriage Rate 6.6% 8.1%
(2.7 to 21.5)
1.5% more





















VERY LOW a, b, c, e
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI). CI: Confidence interval; OR: Odds ratio; RCT: randomised controlled trial.
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
a Downgraded one level for imprecision; no sample size calculation and small number of events
b Downgraded one level for imprecision; odds ratios and confidence intervals show opposing results
c Downgraded one level for indirectness; participants with multiple (3 and over), cavity distorting or submucosal fibroids excluded
d Downgraded one level for imprecision; only one study





























































































































Summary of findings 3.   Monopolar resectoscope compared to bipolar resectoscope for hysteroscopic myomectomy for infertility
Monopolar resectoscope compared to bipolar resectoscope for hysteroscopic myomectomy for infertility
Patient or population: hysteroscopic myomectomy for infertility
Setting: tertiary care
Intervention: bipolar resectoscope use
Comparison: monopolar resectoscope use





























VERY LOW b, c
 
Preterm delivery rate No study data available










VERY LOW b, c
 
Miscarriage rate 8.8% 8.8%
(1.8 to 34.1)
0% fewer







VERY LOW b, c
 
Caesarean section rate No study data available
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI). CI: Confidence interval; OR: Odds ratio; RCT: randomised controlled trial.
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
a Authors defined live birth rate/ongoing pregnancy rate > 30 weeks as a 'successful pregnancy outcome'



























































































































c Downgraded two levels for indirectness; successful pregnancy outcome which included ongoing pregnancy rate and live birth rate; outcomes intended to be primarily fertility
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B A C K G R O U N D
Description of the condition
Fibroids (also known as leiomyomas) are the most common
benign tumours of the female genital tract and occur in about
20% to 50% of women (Yoshino 2010). They have been linked
to many gynaecological problems including heavy menstrual
bleeding and infertility. Fibroids are estimated to be the sole cause
of infertility in less than 3% of cases (Farquhar 2009) and the
mechanisms by which they can aAect fertility vary depending on
the type of fibroid. These mechanisms include causing possible
anatomical changes aAecting the cervix, uterus, tubes and ovaries,
or causing a local endometrial inflammatory reaction leading to
impaired endometrial receptivity, sperm transport or myometrial
contractility (Inagaki 2003; Kroon 2011; Yoshino 2010; Yoshino
2012).
The evidence regarding the eAect of fibroids on fertility depends
mainly on the type of fibroid (submucous (SM), intramural (IM) or
subserous (SS)), and this has been extensively reviewed in several
studies (Somigliana 2007; Klatsky 2008; Pritts 2009; Sunkara 2010;
Metwally 2011). Current evidence suggests the presence of an SM
fibroid is detrimental for fertility, while SS fibroids seem to have
little eAect. The evidence regarding IM fibroids is less conclusive
and there is no clear consensus regarding the eAect of these fibroids
on fertility outcomes.
Description of the intervention
Myomectomy is the procedure by which fibroids are removed
whilst conserving the uterus. This procedure has been reported
as far back as 1845, where the removal of an SS fibroid was
described in the American Journal of Medical Sciences for a woman
thought to have an ovarian cyst. The procedure was successful
despite being performed in the pre-anaesthetic era through a
midline incision. It was not until the early 20th century that
myomectomy by laparotomy gained popularity, largely due to the
haemostatic and surgical techniques developed by Victor Bonney
(Chamberlain 2003). In the late 1970s, laparoscopic myomectomy
was first described for SS fibroids, which extended to IM fibroids
by the early 1990s (Dubuisso 2000).  Since 2015, the routine use
of laparoscopic myomectomy has fallen, following case reports
of iatrogenic spreading of non-benign leiomyomas within the
peritoneum during morcellation (permitting fibroid extraction from
the abdomen through small incisions)(Hall 2015). Consequently,
alternative techniques are favoured.
SM fibroids are currently predominantly managed using
hysteroscopic resection techniques. Hysteroscopic myomectomy
was pioneered largely as a consequence of development of
the urological resectoscope. By the mid 1980s, instrument
modifications led to the development of the gynaecological
resectoscope with a 0° optical lens, a continuous flow irrigation
system using 1.5% glycine and monopolar energy (Hallez
1995). Today, hysteroscopic myomectomy can also be performed
by a bipolar resectoscope. Fundamentally, there are several
important diAerences in electrosurgical systems. Use of a bipolar
resectoscope allows the use of an electrolytic uterine distension
medium such as normal saline (Sardo 2008; Metwally 2015). This
medium, as opposed to the non-conducting distension medium
used in monopolar procedures, can be used without the risk of
adverse eAects such as fluid overload, hyponatraemia and cerebral
oedema (Emanuel 1997). Secondly, with the closed circuit seen in a
bipolar electrosurgical system, the risk of spread of thermal energy
is minimised, allowing a more precise tissue eAect being exerted
(Litta 2014b).
How the intervention might work
For some types of fibroids, such as SM fibroids where a clear
negative eAect on fertility has been demonstrated, myomectomy
may improve fertility by restoring the normal anatomy of the
uterus. With other types of fibroids, such as IM fibroids, the eAect on
fertility and therefore the eAect of intervention on fertility remains
less clear. It is possible that myomectomy may reverse some of
the other associated abnormalities, such as the local endometrial
inflammatory reaction, impaired gamete interaction and abnormal
myometrial contractility, which could lead to improvement in
implantation.
Why it is important to do this review
A societal shiQ in reproductive behaviour has meant women are
more frequently delaying pregnancy until later in reproductive
years. In 2017, 55% of mothers were aged 30 years and over,
compared to 43% in 1997 (OAice for National Statistics 2019). The
delayed timing of pregnancy coincides with the peak incidence
and diagnosis of fibroids. It is therefore predicted that by
2050, the number of myomectomies performed will increase
by 31% (Wechter 2011). The majority of evidence reports an
improvement in pregnancy rates (ranging from 10% to 77%) aQer
myomectomy. This evidence is derived from case series rather
than randomised controlled trials (Farquhar 2009). In addition,
myomectomy carries inherent risks that may be detrimental to
fertility. Myomectomy can reduce chances of conception due to
peritoneal and intrauterine adhesions. Furthermore, the procedure
prolongs time to conception due to surgical recovery. Additionally,
laparoscopic myomectomy and myomectomy by laparotomy or
mini-laparotomy increases the risk of scar rupture in a future
pregnancy. It is therefore essential to determine the relationship
between myomectomy and reproductive outcomes based on high-
quality randomised controlled studies. Furthermore, considering
the heterogenous nature of fibroids, it is essential that clinicians
have clear guidance on when intervention is appropriate based on
type of fibroid (SM, IM, SS).
O B J E C T I V E S
To examine the eAect of myomectomy on fertility outcomes and to
compare diAerent surgical approaches.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Only randomised controlled trials (RCTs) examining the eAect of
myomectomy compared to no treatment or a diAerent surgical
method were eligible for inclusion. Cross-over trials were not
applicable in this context. Studies examining the eAect of fibroid
embolisation were not included as these are included in a separate
review (Gupta 2014).
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Types of participants
Women with uterine fibroids seeking infertility treatment, with or
without symptoms.
Types of interventions
Surgical removal of fibroids by myomectomy at laparotomy,
laparoscopy or hysteroscopy compared to no intervention or a
diAerent surgical method.
Types of outcome measures
Primary outcomes
1. Live birth rate (LBR), defined as the number of live births per
woman
2. Preterm delivery rate (PDR) per woman
Secondary outcomes
3. Clinical pregnancy rate (CPR) per woman
4. Ongoing pregnancy rate (OPR) per woman, defined as a
pregnancy progressing beyond 12 weeks of gestation
5. Miscarriage rate (MR) per woman
6. Caesarean section rate (CSR) per woman
Search methods for identification of studies
Electronic searches
The following databases were searched
1. The Cochrane Gynaecology and Fertility Group (CGF)
Specialised Register of Controlled Trials; PROCITE platform,
searched 26 February 2019 (Appendix 1)
2. CENTRAL via The Cochrane Register of Studies Online (CRSO);
web platform, searched 26 February 2019 (Appendix 2)
3. MEDLINE; Ovid platform, searched from 1946 to 26 February
2019 (Appendix 3)
4. Embase Ovid platform, searched from 1980 to 26 February 2019
(Appendix 4)
5. PsycINFO Ovid platform, searched from 1806 to 26 February
2019 (Appendix 5)
6. CINAHL; (Cumulative Index to Nursing and Allied Health
Literature), EBSCO platform, searched from 1961 to 26 February
2019 (Appendix 6)
The MEDLINE search was combined with the Cochrane highly
sensitive search strategy for identifying randomised trials, which
appears in the Cochrane Handbook of Systematic Reviews of
Interventions Version 5.1.0 (Chapter 6, 6.4.11) (Higgins 2011).
The Embase, PsychINFO and CINAHL search were combined
with trial filters developed by the Scottish Intercollegiate
Guidelines Network (SIGN) (https://www.sign.ac.uk/search-
filters.html). There was no language restriction in these searches.
Other electronic sources of trials included (January 2012 to April
2019).
1. Epistemonikos database (https://www.epistemonikos.org/en)
2. World Health Organization International Clinical Trials Registry
Platform search portal (http://www.who.int/trialsearch/
Default.aspx)
3. LILACS database, which provides a source of trials
from the Portuguese and Spanish speaking world (http://
regional.bvsalud.org/php/index.php?lang=en)
4. PubMed and Google Scholar (for recent trials not yet indexed in
major databases)
5. Grey literature (http://www.opengrey.eu/)
The following journals were also searched electronically (January
2012 to April 2019).
1. Fertility and Sterility
2. Human Reproduction
3. Obstetrics and Gynecology
4. American Journal of Obstetrics and Gynecology
5. British Journal of Obstetrics and Gynaecology





We handsearched reference lists of articles retrieved by the search
and contacted experts in the field to obtain additional data.
Previously excluded studies in this review were reassessed for
eligibility. We also handsearched relevant journals and conference
abstracts that are not covered in the CGF register, in liaison with the
Information Specialist.
Data collection and analysis
Selection of studies
Titles and abstracts were screened independently by two review
authors (GR and MM) to exclude studies that were clearly irrelevant.
Full texts of potentially eligible studies were then retrieved
and examined independently by GR and MM for compliance
with the predefined inclusion criteria. We corresponded with
study investigators as required to clarify study eligibility. Any
disagreements regarding eligibility were resolved at a subsequent
meeting. The selection process was documented with a PRISMA
flow chart.
Data extraction and management
Two review authors (GR and MM) independently extracted data
using a data extraction form designed and pilot-tested by the
review authors. Study characteristics and outcome data were
extracted (see data extraction table for details, Appendix 7). When
studies had multiple publications, the review authors collated all
reports of the same study under a single study ID with multiple
references. Where data were missing or unclear, we corresponded
with study investigators for further data on methods and/or results,
as required.
Assessment of risk of bias in included studies
Two review authors (GR and MM) independently assessed included
studies for risk of bias using the Cochrane 'Risk of bias' assessment
tool (Cochrane Handbook of Systematic Reviews of Interventions
Surgical treatment of fibroids for subfertility (Review)
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Version 5.1.0) (Higgins 2011). Seven domains were assessed:
selection bias (random sequence generation), selection bias
(allocation concealment), attrition bias (incomplete outcome data),
reporting bias (selective reporting), performance bias (blinding of
participants and personnel), detection bias (blinding of outcome
assessors), and other biases (other problems that could put a trial
at high risk of bias). Judgements were assigned as recommended
in the Cochrane Handbook Section 8.5 (Higgins 2011). Any
disagreements were resolved by consensus. We described all the
judgements fully and presented the conclusions in the 'Risk of bias'
tables.
Measures of treatment e;ect
We performed statistical analysis in accordance with the guidelines
developed by the Cochrane Gynaecology and Fertility group.
Dichotomous data were retrieved and analysed using the Mantel-
Haenszel odds ratios (ORs) with 95% confidence intervals (CIs).
Unit of analysis issues
The primary analysis is presented as per woman randomised. If
relevant, rate per clinical pregnancy was used as the denominator
for a secondary analysis of preterm delivery rate, miscarriage rate,
and caesarean section rate as this helps to give a full picture.
Dealing with missing data
In the situation that data were missing, we contacted trial
authors. In situations where attempts for correspondence were
unsuccessful, missing data were analysed using intention-to-treat
basis. Individual values were imputed when missing data included
primary outcome live birth rate only: live birth rate were assumed
not to have occurred in participants without a reported outcome.
We planned that any imputation undertaken would be subjected
to sensitivity analysis. For other outcomes, we analysed only the
available data.
Assessment of heterogeneity
We considered whether the clinical and methodological
characteristics of the included studies were suAiciently similar
for meta-analysis to provide a clinically meaningful summary.
Heterogeneity was assessed using the I2 statistic according to the
guidelines set out in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011). An I2 measurement greater than
50% indicated substantial heterogeneity.
Assessment of reporting biases
In view of the diAiculty of detecting and correcting for publication
bias and other reporting biases, we aimed to minimise their
potential impact by ensuring a comprehensive search for eligible
studies and by being alert for duplication of data. If there were 10
or more studies in an analysis, we planned to use a funnel plot
to explore the possibility of small-study eAects (a tendency for
estimates of the intervention eAect to be more beneficial in smaller
studies).
Data synthesis
When studies were suAiciently similar, dichotomous data for
primary and secondary outcomes were combined using a fixed-
eAect model. An increase in the odds of a particular outcome,
which may be beneficial (for example live birth) or detrimental (for
example preterm delivery), is displayed graphically in the meta-
analysis to the right of the centre-line and a decrease in the odds of
an outcome to the leQ of the centre line.
Subgroup analysis and investigation of heterogeneity
Where possible, outcomes were examined in subgroups depending
on the type of fibroid (SM, IM and SS).
Sensitivity analysis
For comparisons where primary outcomes were deemed as a high
risk of bias, we planned to perform a sensitivity analysis.
Overall quality of the body of evidence: 'Summary of findings'
tables
A 'Summary of findings' table was generated using GRADEpro
and Cochrane methods (Higgins 2011; GRADEpro GDT 2015).
This table evaluated the overall quality of the body of evidence
for the main review outcomes (live birth rate, preterm delivery
rate, clinical pregnancy rate, ongoing pregnancy rate, caesarean
section rate and miscarriage rate) for the main review comparison
(myomectomy versus no treatment). Additional 'Summary of
findings' tables were prepared for the main review outcomes
of other important comparisons (myomectomy performed by
laparotomy or mini-laparotomy versus laparoscopic myomectomy,
and monopolar versus bipolar resectoscope use in hysteroscopic
myomectomy). The quality of the evidence was assessed using the
GRADE criteria: risk of bias, consistency, precision, directness and
publication bias. Judgements regarding the evidence quality (high,
moderate, low or very low) have been justified, documented, and
incorporated into reporting of results for each outcome.
R E S U L T S
Description of studies
See tables for Characteristics of included studies, Characteristics of
excluded studies and Characteristics of ongoing studies
Results of the search
An updated search revealed 1570 articles. Fourteen studies were
potentially eligible and were retrieved in full text. Eleven did
not fulfil the inclusion criteria and were therefore excluded
(Spies 2010; Chatterjee 2012; Kim 2013; Wang 2013; Litta 2014;
Seyam 2015; Kramer 2016 Wang 2016; Saleh 2018 Sato 2018;
Wen 2018). Two studies were not included as they were ongoing
trials (NCT03143114; NCT03796130). One new study was included
(Roy 2017), which was added to the three studies included
in the previous version of the review (Seracchioli 2000; Casini
2006; Palomba 2007). Study selection is documented in a
Preferred Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA) flowchart shown in Figure 1.
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Figure 1.   Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flowchart.
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Figure 1.   (Continued)
 
Included studies
Study design and setting
Four parallel-design randomised controlled trials (RCTs) were
included in the review. Three were single-centre studies
(Seracchioli 2000; Casini 2006; Roy 2017), and one was a multi-
centre study (Palomba 2007) conducted at three university
hospitals. Three studies were conducted in Italy and one was
conducted in India.
Participants
One study (Casini 2006) compared myomectomy (hysteroscopic
myomectomy or myomectomy by laparotomy) to no intervention.
It included 92 women in the intervention group and 89 patients
in the control group. Two studies compared myomectomy at
laparotomy or mini-laparotomy to laparoscopic myomectomy
(Seracchioli 2000; Palomba 2007). These two studies included 86
women in the laparoscopic groups and 91 in the laparotomy/mini-
laparotomy groups. The fourth study (Roy 2017) included women
undergoing hysteroscopic myomectomy by either monopolar or
bipolar resectoscope and included 34 women for each group.
Three studies included only women suAering from infertility
(Seracchioli 2000; Casini 2006; Roy 2017). The fourth study
(Palomba 2007), included women with symptomatic fibroids
and women with unexplained infertility. Only the women with
unexplained infertility were included within the analysis.
Interventions
1. 1/4 studies compared hysteroscopic myomectomy or
myomectomy by laparotomy to no treatment (Casini 2006)
2. 2/4 studies compared myomectomy at laparotomy or mini-
laparotomy to laparoscopic myomectomy (Seracchioli 2000;
Palomba 2007)
3. 1/4 studies compared monopolar resectoscope use to bipolar
resectoscope use in hysteroscopic myomectomy (Roy 2017)
Outcomes
1. 3/4 studies reported live birth (Seracchioli 2000; Palomba 2007;
Roy 2017)
2. 2/4 reported preterm delivery (Seracchioli 2000; Palomba 2007)
3. 4/4 studies reported on clinical pregnancy
4. 2/4 reported ongoing pregnancy (Seracchioli 2000; Roy 2017)
5. 4/4 reported miscarriage
6. 2/4 reported caesarean section (Seracchioli 2000; Palomba
2007)
Characteristics of fibroids
Regarding the type of fibroid, only one study subcategorised
outcomes by the type of fibroid (Casini 2006). Outcomes were
reported separately for intramural; (IM), subserous (SS) and
submucous (SM) fibroids as well as combinations of diAerent types.
DiAerent methods of surgery were used to perform myomectomy
(by either laparotomy or hysteroscopy). However, data were not
provided for these techniques separately. The other studies did not
specify outcomes by type of fibroid (IM or SS), although authors
stated SM fibroids were excluded (Seracchioli 2000; Palomba 2007).
The study completed by Roy 2017 evaluated SM fibroids only as the
intervention under evaluation in this study permits resection of this
type of fibroid only.
Regarding the number and size of fibroid, in the study by Casini
2006, only single fibroids with a maximum diameter of 4 cm were
included. Similarly, Roy 2017 included participants with fibroids
under 3 cm in diameter, but allowed a maximum of two fibroids.
Size and number were more variable in the other two included
studies. In the study by Palomba 2007, participants had less than
three fibroids, with a diameter between 3 cm and 10 cm. In the study
by Seracchioli 2000, a maximum of three fibroids were included
with fibroids being 5 cm or more.
Further details of included studies can be found in the table
Characteristics of included studies.
Excluded studies
In this version of the review 11 studies were excluded for the
following reasons:
1. 10/11 were not RCTs (Spies 2010; Chatterjee 2012; Kim 2013;
Wang 2013; Litta 2014; Seyam 2015; Wang 2016; Saleh 2018; Sato
2018; Wen 2018);
2. 1/11 assessed an intervention outside of our review (Kramer
2016).
Characteristics of all excluded studies can be found in the table
Characteristics of excluded studies.
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Ongoing studies
There are two ongoing clinical trials (NCT03143114; NCT03796130).
Risk of bias in included studies
'Risk of bias' assessment focused on seven domains: generation of
allocation sequence, concealment of allocation sequence, blinding
of participants and personnel, blinding of outcome assessor,
incomplete outcome data, selective outcome reporting and other
bias (e.g. publication bias). Details of findings can be found in the
relevant 'Risk of bias' summary figure (Figure 2) and the table
Characteristics of included studies.
 




All four studies were at low risk of selection bias related to sequence
generation as they used computer randomisation or a random
numbers table.
Allocation concealment
Two studies were at low risk of selection bias related to allocation
concealment as the random allocation sequence was concealed
in a closed and dark-coloured envelope until immediately prior to
surgery (Palomba 2007, Roy 2017). The other two studies did not
describe the method used and were therefore deemed to have an
unclear risk of this bias.
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Blinding
Blinding of participants and personnel (performance bias)
As expected, blinding of participants and personnel was not
performed in surgical studies. Therefore, the absence of blinding
was not considered a source of bias.
Blinding of outcome assessors (detection bias)
It was unclear in all four studies if outcome assessors were blinded
to which intervention a participant received.
Incomplete outcome data
All studies analysed all women randomised and we judged them to
be at low risk of bias.
Selective reporting
Three of four studies reported on all prespecified outcomes and
therefore all three studies were judged to be at low risk of bias
(Seracchioli 2000; Casini 2006; Palomba 2007). The fourth study
only reported on four of five pre-specified reproductive outcomes
and was therefore deemed high risk of reporting bias (Roy 2017).
Furthermore, this study combined outcomes and reported them
as a single entity. 'Successful pregnancy outcome' was reported as
a combination of live birth rate and ongoing pregnancy rate (> 30
weeks), without explanation. Finally, whilst Casini 2006 reported on
all pre-specified outcomes, it could be considered to be at a high
risk of reporting bias as live birth rate was not reported despite the
trial lasting seven years.
Other potential sources of bias
We found no other potential sources of bias in any of the included
studies.
E;ects of interventions
See: Summary of findings for the main comparison Myomectomy
compared to no treatment for fibroids for infertility; Summary of
findings 2 Laparoscopic myomectomy compared to myomectomy
by laparotomy or mini-laparotomy for fibroids for infertility;
Summary of findings 3 Monopolar resectoscope compared to
bipolar resectoscope for hysteroscopic myomectomy for infertility
1. Comparison of myomectomy versus no intervention.
Results were reported from one study (Casini 2006).
Primary outcomes
1.1 Live birth rate: not reported.
1.2 Preterm delivery rate: not reported.
Secondary outcomes
1.3 Clinical pregnancy rate: we are uncertain whether myomectomy
improves clinical pregnancy rate for intramural (IM) fibroids (OR
1.88, 95% CI 0.57 to 6.14, participants = 45; studies = 1; very low-
quality evidence), submucous (SM) fibroids (OR 2.04, 95% CI 0.62
to 6.66; participants = 52; studies = 1; very low-quality evidence),
combined intramural/subserous (IM/SS) fibroids (OR 2.00, 95%
CI 0.40 to 10.09; participants = 31; studies = 1; very low-quality
evidence) and combined intramural/submucous (IM/SM) fibroids
(OR 3.24, 95% CI 0.72 to 14.57; participants = 42; studies = 1; very
low-quality evidence) (Analysis 1.1: see Figure 3).
 
Figure 3.   Forest plot of comparison 1: Myomectomy versus no intervention, Outcome 1.3: Clinical pregnancy rate.
 
For IM fibroids, chance of pregnancy without myomectomy was
assumed to be 41%, compared to between 28% and 81% with
myomectomy. For SM fibroids, chance of pregnancy without
myomectomy was assumed to be 27%, compared to between
19% and 71% with myomectomy. For IM/SS fibroids, chance
of pregnancy without myomectomy was assumed to be 21%,
compared to between 10% and 73% with myomectomy. For IM/SM
fibroids, chance of pregnancy without myomectomy was assumed
to be 15%, compared to between 11% and 72% with myomectomy.
1.4 Ongoing pregnancy rate: not reported.
1.5 Miscarriage rate: we are uncertain whether myomectomy
reduces miscarriage rate for IM fibroids (OR 1.33, 95% CI 0.26 to 6.78;
45 participants; one study; very low-quality evidence), SM fibroids
(OR 1.27, 95% CI 0.27 to 5.97; 52 participants; one study; very
low-quality evidence), combined IM/SS fibroids (OR 0.80, 95% CI
0.10 to 6.54; 31 participants; one study; very low-quality evidence)
and combined IM/SM fibroids (OR 2.00, 95% CI 0.32 to 12.33; 42
participants; one study; very low-quality evidence).
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For IM fibroids, chance of miscarriage without myomectomy was
14% compared to between 4% and 52% with myomectomy. For
SM fibroids, chance of miscarriage without myomectomy was 14%
compared to between 4% and 49% with myomectomy. For IM/
SS fibroids, chance of miscarriage without myomectomy was 14%
compared to between 2% and 52% with myomectomy. For IM/
SM fibroids, chance of miscarriage without myomectomy was 10%
compared to between 3% and 58% with myomectomy.
1.6 Caesarean section rate: not reported.
2. Comparison of myomectomy at laparotomy or mini-
laparotomy versus laparoscopic myomectomy
Results were reported from two studies (Seracchioli 2000; Palomba
2007).
Primary outcomes
2.1 Live birth rate: we are uncertain whether laparoscopic
myomectomy improves live birth rate compared to myomectomy
at laparotomy or mini-laparotomy (OR 0.80, 95% CI 0.42 to 1.50;
participants = 177; studies = 2; I2 = 0%; very low-quality evidence).
This evidence suggests that the birth rate in those receiving
myomectomy by laparotomy or mini-laparotomy is assumed to
be 36%, compared to between 19% and 46% for those receiving
laparoscopic myomectomy. (Analysis 2.1: see Figure 4).
 
Figure 4.   Forest plot of comparison 2: Laparoscopic myomectomy versus myomectomy at laparotomy or mini-
laparotomy, Outcome 2.1: Live birth rate.
 
2.2 Preterm delivery rate: we are uncertain whether laparoscopic
myomectomy reduces preterm delivery rate compared to
myomectomy at laparotomy or mini-laparotomy (OR 0.70, 95% CI
0.11 to 4.29; participants = 177; studies = 2; I2 = 0%; very low-quality
evidence). This evidence suggests that the preterm delivery rate in
those receiving myomectomy by laparotomy or mini-laparotomy is
assumed to be 3%, compared to between 0% and 13% for those
receiving laparoscopic myomectomy. (Analysis 2.2: see Figure 5).
 
Figure 5.   Forest plot of comparison 2: Laparoscopic myomectomy versus myomectomy at laparotomy or mini-
laparotomy, Outcome 2.2: Preterm delivery rate.
 
Secondary outcomes
2.3 Clinical pregnancy rate: we are uncertain whether laparoscopic
myomectomy improves clinical pregnancy rate compared to
myomectomy at laparotomy or mini-laparotomy (OR 0.96, 95% CI
0.52 to 1.78; participants = 177; studies = 2; I2 = 0%; very low-quality
evidence) (Analysis 2.3). This evidence suggests that the clinical
pregnancy rate in those receiving myomectomy by laparotomy
or mini-laparotomy is 45% compared to between 30% and 59%
receiving laparoscopic myomectomy.
2.4 Ongoing pregnancy rate: we are uncertain whether laparoscopic
myomectomy improves ongoing pregnancy rate compared to
myomectomy at laparotomy or mini-laparotomy (OR 1.16, 95%
CI 0.26 to 10.04, participants = 115; studies = 1; very low-quality
evidence) (Analysis 2.4). This evidence suggests that the chances
of an ongoing pregnancy in those receiving myomectomy by
laparotomy or mini-laparotomy is assumed to be 3%, the chance
with laparoscopic myomectomy would be between 1% and 26%.
2.5 Miscarriage rate: we are uncertain whether laparoscopic
myomectomy reduces miscarriage rate compared to myomectomy
at laparotomy or mini-laparotomy (OR 1.25, 95% CI 0.40 to 3.89;
participants = 177; studies = 2; I2 = 0%; very low-quality evidence)
(Analysis 2.5). This evidence suggests that the chances of a
miscarriage in those receiving myomectomy by laparotomy or mini-
laparotomy is assumed to be 7%, the chance with laparoscopic
myomectomy would be between 3% and 22%.
2.6 Caesarean section rate: we are uncertain whether laparoscopic
myomectomy improves caesarean section rate compared to
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myomectomy at laparotomy or mini-laparotomy (OR 0.69, 95%
CI 0.34 to 1.39; participants = 177; studies = 2; I2 = 21%; very
low-quality evidence) (Analysis 2.6). This evidence suggests that
the chances of having a caesarean section in those receiving
myomectomy by laparotomy or mini-laparotomy is assumed to
be 28%, compared to between 11% and 35% in those receiving
laparoscopic myomectomy.
3. Comparison of monopolar versus bipolar resectoscope use
in hysteroscopic myomectomy
Results were reported from one study (Roy 2017).
Primary outcomes
3.1 Live birth/ongoing pregnancy rate (defined by authors as a
'successful pregnancy outcome' > 30 weeks): we are uncertain
whether bipolar resectoscope use improves live birth/ongoing
pregnancy rate compared to monopolar resectoscope use in
hysteroscopic myomectomy (OR 0.86, 95% CI 0.30 to 2.50,
participants = 68; studies = 1; very low-quality evidence). Therefore
meaning that in those receiving monopolar resectoscope use in
hysteroscopic myomectomy, the birth rate was assumed to be
26.4%, compared to between 10% and 47% in those who had a
myomectomy with a bipolar resectoscope. (Analysis 3.1: see Figure
6).
 
Figure 6.   Forest plot of comparison 3: Monopolar versus bipolar resectoscope use in hysteroscopic myomectomy,
Outcome 3.1 Live birth rate/Ongoing pregnancy rate.
 
3.2 Preterm delivery rate: not reported.
Secondary outcomes
3.3 Clinical pregnancy rate: we are uncertain whether bipolar
resectoscope use improves clinical pregnancy rate compared to
monopolar resectoscope use in hysteroscopic myomectomy (OR
0.88, 95% CI 0.33 to 2.36, participants = 68; studies = 1; very low-
quality evidence) (Analysis 3.2). Therefore meaning that in those
receiving a myomectomy using a monopolar resectoscope, clinical
pregnancy rate was assumed to be 33.3%, compared to between
15% and 57% in those who had a myomectomy with a bipolar
resectoscope.
3.4 Ongoing pregnancy rate: reported above with live birth rate.
3.5 Miscarriage rate: we are uncertain whether bipolar resectoscope
use reduces miscarriage rate compared to monopolar resectoscope
use in hysteroscopic myomectomy (OR 1.00, 95% CI 0.19 to 5.34;
participants = 68; studies = 1; very low-quality evidence) (Analysis
3.3). Therefore meaning that in those receiving a myomectomy
using a monopolar resectoscope, miscarriage rate was assumed
to be 9%, compared to between 2% and 34% in those who had a
myomectomy with a bipolar resectoscope.
3.6 Caesarean section rate: not reported.
E;ects of subgroup analysis
Subgroup analysis permitted examination of eAect of intervention
on fibroids in diAerent locations. Only one study reported on
location of fibroids individually, which meant there were too few
studies to perform the planned subgroup analysis.
E;ects of sensitivity analysis
As no single comparison included a study with a primary outcome
deemed as a high risk of bias, a sensitivity analysis was not
performed. Furthermore, there were too few studies to conduct
sensitivity analysis.
D I S C U S S I O N
Summary of main results
This review included four randomised controlled studies (RCTs)
(442 participants) that examined the eAect of myomectomy on
fertility outcomes. When examining this issue, two questions
need to be answered. Firstly, whether myomectomy leads to an
improvement in fertility outcomes; and secondly, if there is a
beneficial eAect what would be the ideal surgical approach?
The first question was addressed by only one randomised
controlled trial (Casini 2006). This study appropriately examined
reproductive outcomes separately for the diAerent types of
fibroids. We are uncertain of the eAect myomectomy had on both
clinical pregnancy and miscarriage rate compared to no treatment.
Unfortunately this study did not report on either primary outcome
(live birth rate or preterm delivery rate), despite the study lasting
seven years. Furthermore, the study collectively reported on
myomectomies performed either by laparotomy or hysteroscopy,
meaning separate analysis of these two very diAerent surgical
approaches could not be performed.
The second question was addressed by three studies (Seracchioli
2000, Palomba 2007 and Roy 2017). Two studies compared
myomectomy at laparotomy or mini-laparotomy to laparoscopic
myomectomy (Palomba 2007; Seracchioli 2000). It is uncertain
which surgical method is superior when comparing these
approaches on fertility outcomes (live birth, preterm delivery,
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clinical pregnancy, ongoing pregnancy, miscarriage and caesarean
section rate). The third study (Roy 2017) compared monopolar
versus bipolar resectoscope use in hysteroscopic myomectomy. It
is uncertain which of the two approaches is superior regarding any
of the reported fertility outcomes (live birth rate, clinical pregnancy
rate and miscarriage rate).
Overall completeness and applicability of evidence
1. In determining the eAect of myomectomy on fertility outcomes,
fibroids are not a single entity but vary widely regarding site and
size with diAerent fertility eAects being reported for intramural (IM),
subserous (SS) and submucous (SM) fibroids. There is currently
a consensus regarding the fertility eAects for SS and SM fibroids,
based on the findings of several case-controlled studies and meta-
analyses. These studies suggest SM fibroids have been found to
be associated with a negative impact on fertility while SS fibroids
appeared to have little to no eAect (Pritts 2009). Opinion regarding
IM fibroids is more controversial. Some studies have suggested a
negative eAect on fertility (Pritts 2009; Sunkara 2010), while a more
recent study has suggested that in fact the quality of evidence is too
low to draw any conclusions (Metwally 2011). In the midst of such
controversy, clinicians are leQ with a diAicult task when deciding
whether or not to surgically intervene, particularly when surgical
intervention may itself pose a risk to fertility due to the risk of
intrauterine and pelvic adhesions.
Unfortunately the current evidence does not settle this dilemma
as only one study addressed reproductive outcomes separately
for diAerent types of fibroids (Casini 2006). The sample size was
relatively small and therefore inadequate to draw a firm conclusion.
Furthermore, the study was limited only to single fibroids of a
maximum size of 4 cm. Finally, the study did not report on the live
birth rate.
2. For type of surgical approach, evidence regarding the use of
laparoscopy versus laparotomy was more comprehensive. While
the use of the laparoscopic approach may oAer advantages
regarding postoperative recovery and morbidity, the current study
was unable to identify any clear benefit for the laparoscopic
approach regarding fertility outcomes. On the positive side,
despite the small number of studies, both studies provided
evidence regarding our primary outcome, live birth rate, as
well as several secondary outcomes. Furthermore, information
is provided regarding late pregnancy outcomes, that is preterm
delivery and caesarean section rates. However, the diAiculty with
comparing the two abdominal approaches remains the fact that
there is a large variation in surgical practice, for example level
of skill, surgical technique and use of anti-adhesion agents,
all of which may influence fertility outcomes. Therefore, until
a larger number of studies is available, it would be diAicult
to draw a firm conclusion. Finally, SM fibroids are thought
to have the strongest association with impaired fertility, with
hysteroscopic myomectomy considered the most appropriate
surgical approach. Despite the potential fertility implications,
there is limited high-quality evidence available evaluating the
intervention on reproductive outcomes. Only one RCT, attempts
to make progress analysing this approach (Roy 2017). This
study compared electrosurgical systems (monopolar to bipolar).
Previously, both techniques have been shown to have successful
pregnancy outcomes (Makris 2007; Litta 2014a). Results found
that there was minimal diAerence between the two interventions
on reproductive outcomes. Outside of our assessed outcomes, a
greater diAerence was seen. Bipolar resectoscope use had better
surgical outcomes, suggesting it would be a safer alternative.
Quality of the evidence
For the eAect of myomectomy on fertility outcomes, the study by
Casini 2006 had the advantage of clearly defining the type of fibroid,
by only including single fibroids of 4 cm maximum diameter.
Information regarding larger or multiple fibroids is however clearly
lacking. Allocation concealment was not clear raising the possibility
of selection bias. Furthermore, abdominal myomectomies and
hysteroscopic myomectomies are two very diAerent techniques
dealing with diAerent types of fibroids and with very diAerent
potential side eAects that may have a negative impact on fertility
(that is intrauterine versus peritubal adhesions). Therefore the
inclusion of these two surgical approaches into one study group has
the potential to introduce bias and further compromise the quality
of the evidence.
For the surgical approach for myomectomy, three studies provided
evidence. Only two studied myomectomy at laparotomy or mini-
laparotomy compared to laparoscopic myomectomy (Seracchioli
2000; Palomba 2007), and therefore the evidence should be
viewed with caution. The study by Seracchioli 2000 was not clear
regarding allocation concealment. However a positive aspect of the
analysis is that all outcomes were associated with no evidence of
significant heterogeneity. The fourth study compared monopolar
resectoscope use to bipolar resectoscope use in hysteroscopic
myomectomy. As only one study provided evidence for this
comparison, with only 60 participants, evidence must be viewed
with caution. This study did perform a power calculation (Roy
2017). However, only 60 participants in total were recruited, despite
the completed power calculation indicating needing a threshold
of 100 participants per group for significant findings. Furthermore,
this study had a high risk of reporting bias, as intended outcomes
did not match reported outcomes.
Overall, the quality of evidence in this review was very low quality.
Three studies included in the review did not perform a power
calculation or explain the rationale behind their recruited sample
size (Seracchioli 2000; Casini 2006; Palomba 2007). Furthermore,
Palomba 2007 describes halting recruitment following an interim
analysis due to quote "too little or clinically irrelevant di!erence
in outcomes to continue the study to obtain an adequate power".
As described by Kadam 2010, a sample size should always be
performed prior to starting a trial and should not be altered during
the study, meaning all three studies are likely to be underpowered
and can be criticised.
Potential biases in the review process
Review authors MM and GR independently screened and identified
relevant studies making it unlikely that any studies have been
missed. Furthermore, a final search was performed at the
completion of the review to ensure that no new studies had been
published during preparation of the manuscript. However, despite
all our eAorts, there is still a possibility that studies in press may
have been missed.
All review authors were in agreement regarding the inclusion or
exclusion of any newly identified study, and therefore it is unlikely
that a misjudgement has been made leading to the non-inclusion
of any relevant study.
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Agreements and disagreements with other studies or
reviews
This review remains the only systematic review and meta-analysis
to assess the role of myomectomy on fertility outcomes. SInce
the review was last updated in 2012 (Metwally 2012), one new
study has been included (Roy 2017) and primary outcomes have
been reassessed. The previous version included two comparisons
evaluating myomectomy compared to no treatment and diAerent
surgical approaches to myomectomy. The addition of a new study
has permitted an expansion of the review to include a third
comparison evaluating use of diAerent electrosurgical systems in
hysteroscopic myomectomy. Additionally, preterm delivery rate
has been promoted to a primary outcome.The main findings
however remain unchanged, where the insuAicient number of
studies prevents us from drawing a firm conclusion.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
There remains limited evidence to determine the role of
myomectomy for infertility in women with fibroids. If the decision
is made to have a myomectomy, the current evidence does not
indicate a superior method (laparoscopy, laparotomy or diAerent
electrosurgical systems) to improve rates of live birth, preterm
delivery, clinical pregnancy, ongoing pregnancy, miscarriage, or
caesarean section. Furthermore, the existing evidence needs to be
viewed with caution due to the small number of events, minimal
number of studies and very low-quality evidence.
Implications for research
There is an urgent need for high-quality randomised controlled
studies to determine the role of myomectomy for fertility
management, given that fibroids are not a single entity but a
wide spectrum of tumours.  Studies should therefore take into
consideration the following points.
1. Priority should be given to studies comparing myomectomy to
no intervention rather than comparing diAerent types of surgical
interventions. If a beneficial eAect for surgery is demonstrated
then the next step would be to focus on the type of surgical
approach.
2. Studies should classify outcomes by the size and type of fibroid
(intramural (IM), subserous (SS) and submucous (SM)) with clear
definitions in the inclusion and exclusion criteria.
3. Inclusion of patients in future studies with only unexplained
infertility would minimise the eAect of other confounding factors
such as diAerences in the cause of infertility.
A C K N O W L E D G E M E N T S
This review is an updated version of the initial Cochrane review by
Anthony N GriAiths, Arianna D'Angelo and Nazar N Amso (GriAiths
2006). We would like to acknowledge their valuable contribution.
Surgical treatment of fibroids for subfertility (Review)









Cochrane Database of Systematic Reviews
R E F E R E N C E S
 
References to studies included in this review
Casini 2006 {published data only}
Casini ML, Rossi F, Agostini R, Unfer V. EAects of the
position of fibroids on fertility. Gynecological Endocrinology
2006;22(2):106-9.
Palomba 2007 {published data only}
Palomba S, Zupi E, Falbo A, Russo T, Marconi D, Tolino A, et
al. A multicenter randomized, controlled study comparing
laparoscopic versus minilaparotomic myomectomy:
reproductive outcomes. Fertility and Sterility 2007;88(4):933–41.
Roy 2017 {published data only}
Roy KK, Metta S, Kansal Y, Kumar S, Singhal S, Vanamail P. A
prospective randomized study comparing unipolar versus
bipolar hysteroscopic myomectomy in infertile women. Journal
of Human Reproductive Sciences 2017;10(3):185-93.
Seracchioli 2000 {published data only}
Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S,
Bulletti C, et al. Fertility and obstetric outcome aQer
laparoscopic myomectomy of large myomata: a randomized
comparison with abdominal delivery. Human Reproduction
2000;15(12):2663-8.
 
References to studies excluded from this review
Bernard 2000 {published data only}
Bernard G, Darai E, Poncelet C, Benifla JL, Madelenat P. Fertility
aQer hysteroscopic myomectomy: eAect of intramural myomas
associated. European Journal of Obstetrics, Gynecology, and
Reproductive Biology 2000;88:85-90.
Bulletti 1999 {published data only}
Bulletti C, De Ziegler D, Polli V, Flamigni C. The role of
leiomyomas in infertility. Journal of the American Association of
Gynaecologic Laparoscopists 1999;6(4):441-5.
Bulletti 2004 {published data only}
Bulletti C, DE Ziegler D, Levi Setti P, Cicinelli E, Polli V,
Stefanetti M. Myomas, pregnancy outcome, and in vitro
fertilization. Annals of the New York Academy of Sciences
2004;1034:84-92.
Campo 2003 {published data only}
Campo S, Campo V, Gambadauro P. Reproductive outcome
before and aQer laparoscopic or abdominal myomectomy for
subserous intramural myomas. European Journal of Obstetrics,
Gynecology, and Reproductive Biology 2003;110:215-9.
Chang 2011 {published data only}
Chang WC, Chou LY, Chang DY, Huang PS, Huang SC, Chen SY,
et al. Simultaneous laparoscopic uterine artery ligation and
laparoscopic myomectomy for symptomatic uterine myomas
with and without in situ morcellation. Human Reproduction
2011;26(7):1735-40.
Chatterjee 2012 {published data only}
Chatterjee S, Chatterjee A, Chowdhury R, Dey S, Ganguly D.
Fertility promoting laparoscopic surgery: our experience.
Journal of South Asian Federation of Obstetrics and Gynaecology
2012;4:12-6.
Chong 1988 {published data only}
Chong RK, Thong PH, Tan SL, Thong P, Salmon YM.
Myomectomy: Indications, results of surgery and relation to
fertility. Singapore Medical Journal 1988;29:35-7.
Darai 1997 {published data only}
Darai E, Dechaud H, Benifla JL, Renolleau C, Panel P,
Madelenat P. Fertility aQer laparoscopic myomectomy:
preliminary results. Human Reproduction 1997;12(9):1931-4.
Dubuisson 2000 {published data only}
Dubuisson JB, Fauconnier A, Chapron C, Kreiker G, Norgaard C.
Reproductive outcome aQer laparoscopic myomectomy
in infertile women. Journal of Reproductive Medicine
2000;45(1):23-30.
Fauconnier 2000 {published data only}
Fauconnier A, Dubuisson J, Ancel P, Chapron C. Prognostic
factors of reproductive outcome aQer myomectomy in infertile
patients. Human Reproduction 2000;15(8):1751-7.
Fernandez 2001 {published data only}
Fernandez H, Sefrioui O, Virelizier C, Gervaise A, Gomel V,
Frydman R. Hysteroscopic resection of submucosal
myomas in patients with infertility. Human Reproduction
2001;16(7):1489-92.
Gatti 1989 {published data only}
Gatti D, Falsetti L, Viani A, Gastaldi A. Uterine fibromyoma
and sterility: role of myomectomy. Acta Europaea Fertilitatis
1989;20(1):11-3.
Gehlbach 1993 {published data only}
Gehlbach DL, Sousa RC, Carpeter SE, Rock JA. Abdominal
myomectomy in the treatment of infertility. International
Journal of Gynaecology and Obstetrics 1993;40(1):45-50.
Giatras 1999 {published data only}
Giatras K, Berkeley AS, Noyes N, Licciardi F, Lolis D, Grifo JA.
Fertility aQer hysteroscopic resection of submucous
myomas. Journal of the American Association of Gynecologic
Laparoscopists 1999;6(2):155-8.
Kim 2013 {published data only}
Kim M, Uhm Y, Kim J, Jee B, Kim Y. Obstetric outcomes aQer
uterine myomectomy: Laparoscopic versus laparotomic
approach. Obstetrics and Gynecology Science 2013;56:375-81.
Kramer 2016 {published data only}
Krämer B, Hahn M, Taran F, Kraemer D, Isaacson KB, Brucker SY.
Interim analysis of a randomized controlled trial comparing
laparoscopic radiofrequency volumetric thermal ablation of
Surgical treatment of fibroids for subfertility (Review)









Cochrane Database of Systematic Reviews
uterine fibroids with laparoscopic myomectomy.. International
Journal of Gynecology and Obstetrics 2016;133:206-11.
Li 1999 {published data only}
Li TC, Mortimer R, Cooke ID. Myomectomy: a retrospective study
to examine reproductive performance before and aQer surgery.
Human Reproduction 1999;14(7):1735-40.
Litta 2014 {published data only}
Litta P, Conte L, Marchi F, Saccardi C, Angioni S. Pregnancy
outcome aQer hysteroscopic myomectomy. Gynecological
Endocrinology 2014;30(2):149-52.
Malzoni 2003 {published data only}
Malzoni M, Rotondi M, Perone C, Labriola D, Ammaturo F,
Izzo A, et al. Fertility aQer laparoscopic myomectomy of large
uterine myomas: operative technique and preliminary results.
European Journal of Gynaecological Oncology 2003;24(1):79-82.
Narayan 1994 {published data only}
Narayan R, Goswamy K. Treatment of submucous fibroids, and
the outcome of assisted conception. Journal of the American
Association of Gynecologic Laparoscopists 1994;1(4 pt 1):307-11.
Ribeiro 1999 {published data only}
Ribeiro SC, Reich H, Rosenberg J, Guglielminetti E, Vidali A.
Laparoscopic myomectomy and pregnancy outcome in infertile
patients. Fertility and Sterility 1999;71(3):571-4.
Rossetti 2001 {published data only}
Rossetti A, Sizzi O, Soranna L, Lanzone A. Fertility outcome: long
term results aQer laparoscopic myomectomy. Gynecological
Endocrinology 2001;15:129-34.
Saleh 2018 {published data only}
Saleh HS, Mowafy HE, Hameid AA, Sherif HE, Mahfouz E.M.
Does uterine fibroid adversely aAect obstetric outcome of
pregnancy?. BioMed Research International 2018;2018:1-5.
Sato 2018 {published data only}
Sato M, Hara S, Suyama F, Beck W, Mukoda Y. Impact of
laparoscopic myomectomy on reproductive and obstetric
outcomes in patients with intramural myomas. Human
Reproduction 2018;33:478-9.
Seyam 2015 {published data only}
Seyam E, Hassan M, Gad M, Mahmoud H, Ibrahum M. Pregnancy
outcome aQer oAice microhysteroscopy in women with
unexplained infertility. International Journal of Fertility and
Sterility 2015;9:168-75.
Shokeir 2010 {published data only}
Shokeir T, El-Shafei M, Yousef H, Allam AF, Sadek E. Submucous
myomas and their implications in the pregnancy rates of
patients with otherwise unexplained primary infertility
undergoing hysteroscopic myomectomy: a randomized
matched control study. Fertility and Sterility 2010;94(2):724-9.
Spies 2010 {published data only}
Spies J, Bradley L, Guido R, Maxwell L, Levine B, Coyne K.
Outcomes from leiomyoma therapies. Obstetrics and
Gynecology 2010;116(3):641-52.
Sudik 1996 {published data only}
Sudik R, Husch K, Stellar J, Daume E. Fertility and pregnancy
outcome aQer myomectomy in sterility patients. European
Journal of Obstetrics, Gynecology, and Reproductive Biology
1996;65:209-14.
Ubaldi 1995 {published data only}
Ubaldi F, Tournaye H, Camus M, Van der Pas H, Gepts E,
Devroey P. Fertility aQer hysteroscopic myomectomy. Human
Reproduction Update 1995;1(1):81-90.
Varasteh 1999 {published data only}
Varasteh NN, Varasteh RS, Neuwirth BL, Keltz MD. Pregnancy
rates aQer hysteroscopic polypectomy and myomectomy in
infertile women. Obstetrics and Gynecology 1999;94(2):168-71.
Vercellini 1999a {published data only}
Vercellini P, Zaina B, Yaylayan L, Pisacreta A, De Giorgio O,
Crosignani PG. Hysteroscopic myomectomy: Long term eAect
on menstrual pattern and fertility. Obstetrics and Gynecology
1999;94(3):341-7.
Vercellini 1999b {published data only}
Vercellini P, Maddalena S, de Giorgi O, Pesole A, Ferrari L,
Crosignani PG. Determinants of reproductive outcome aQer
abdominal myomectomy for infertility. Fertility and Sterility
1999;72(1):109-14.
Wang 2013 {published data only}
Wang CJ, Yu HT, Wu PJ, Su H, Wu KY, Han CM. Laparoscopic
myomectomy instead of hysteroscopic myomectomy for large
submucous fibroids. Gynecology and Minimally Invasive Therapy
2013;2:93-5.
Wang 2016 {published data only}
Wang H, Zhao J, Li X, Li P, Lu C, Tian S, Wang ZH. The indication
and curative eAect of hysteroscopic and laparoscopic
myomectomy for type II submucous myomas. BMC Surgery
2016;16(9):1-7.
Wen 2018 {published data only}
Wen KC, Sung PL, Chang WH, Horng HC, Chen YJ, Lee WL, et al. A
case-control study to compare the outcome of women treated
by two minimally invasive procedures- ultraminilaparotomy
myomectomy and laparoscopic myomectomy. Taiwanese
Journal of Obstetrics and Gynecology 2018;57:264-9.
Yarali 2002 {published data only}
Yarali H, Bukulmez O. The eAect of intramural and subserous
uterine fibroids on implantation and clinical pregnancy rates in
patients having intracytoplasmic sperm injection. Archives of
Gynecology and Obstetrics 2002;266:30-3.
 
Surgical treatment of fibroids for subfertility (Review)









Cochrane Database of Systematic Reviews
References to ongoing studies
NCT03143114 {unpublished data only}
NCT03143114. EAect of myomectomy for intramural myoma on
fertility outcomes in infertile women [EAect of myomectomy
for intramural myoma on fertility outcomes in infertile women:
a randomized clinical trial]. clinicaltrials.gov/ct2/show/
NCT03143114 (first received 8 May 2017).
NCT03796130 {unpublished data only}
NCT03796130. Does myomectomy for intramural fibroid
improve ART outcome? (MIFART) [Does myomectomy for
intramural fibroid improve ART outcome? A randomized
controlled trial]. clinicaltrials.gov/ct2/show/NCT03796130 (first




Chamberlain G. The master of myomectomy. Journal of the
Royal Society of Medicine 2003;96(6):302-4.
Dubuisso 2000
Dubuisso JB, Fauconnier A, Babaki-Fard K, Chapron C.
Laparoscopic myomectomy: a current view. Human
Reproduction Update 2000;6(6):588-94.
Emanuel 1997
Emanuel M, Hart A, Wamsteker K, Lammes F. An analysis of
fluid loss during transcervical resection of submucous myomas.
Fertility and Sterility 1997;68:881-6.
Farquhar 2009
Farquhar C. Do uterine fibroids cause infertility and should they
be removed to increase fertility?. BMJ 2009;16:338.
GRADEpro GDT 2015 [Computer program]
GRADEpro GDT. GRADEpro Guideline Development Tool
[SoQware]. MxMaster University: Evidence Prime, Inc.. McMaster
University: Evidence Prime, Inc., 2015.
Gupta 2014
Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery
embolization for symptomatic uterine fibroids. Cochrane
Database of Systematic Reviews 2014, Issue 12. [DOI:
10.1002/14651858.CD005073.pub4]
Hall 2015
Hall T, Lee S, Boruta D, Goodman A. Medical device safety and
surgical dissemination of unrecognized uterine malignancy:
morcellation in minimally invasive gynecologic surgery.
Oncologist 2015;20(11):1274-82.
Hallez 1995
Hallez JP. Single-stage total hysteroscopic myomectomies:
indications, techniques, and results. Fertility and Sterility
1995;63:703-8.
Higgins 2011
Higgins JP, Green S (editors). Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 (updated
March 2011). The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.
Inagaki 2003
Inagaki N, Ung L, Otani T, Wilkinson D, Lopata A. Uterine cavity
matrix metalloproteinases and cytokines in patients with
leiomyoma, adenomyosis or endometrial polyp. European
Journal of Obstetrics, Gynecology, and Reproductive Biology
2003;111:197-203.
Kadam 2010
Kadam P, Bhalerao S. Sample size calculation. International
Journal of Ayurveda Research 2010;1(1):55-7.
Klatsky 2008
Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and
reproductive outcomes: a systematic review from conception
to delivery. American Journal of Obstetrics and Gynecology
2008;198(4):357–66.
Kroon 2011
Kroon B, Johnson N, Chapman M, Yazdani A, Hart R,
Australasian CREI Consensus Expert Panel on Trial evidence
(ACCEPT) group. Fibroids in infertility--consensus statement
from ACCEPT (Australasian CREI Consensus Expert Panel
on Trial evidence). The Australian & New Zealand Journal of
Obstetrics & Gynaecology 2011;51(4):289-95.
Litta 2014a
Liita P, Conte L, Marchi F, Saccardi C, Angioni S. Pregnancy
outcome aQer hysteroscopic myomectomy. Gynecological
Endocrinology 2014;30:149-52.
Litta 2014b
Liita P, Leggieri C, Conte L, Dalla ToAola A, Multinu F, Angioni S.
Monopolar versus bipolar device: Safety, feasibility, limits
and perioperative complications in performing hysteroscopic
myomectomy. Clinical and Experiemental Obstetrics &
Gynecology 2014;41:335-338.
Makris 2007
Makris N, Vomvolaki E, Mantzaris G, Kalmantis K, Hatzipappas J,
Antsaklis A. Role of bipolar rectoscope in subfertile women
with submucous myomas and menstrual disorders. Journal of
Obstetrics and Gynaecology Research 2007;33:849-54.
Metwally 2011
Metwally M, Farquhar CM, Li TC. Is another meta-analysis on
the eAects of intramural fibroids on reproductive outcomes
needed?. Reproductive Biomedicine Online 2011;23(1):2-14.
Metwally 2015
Metwally M, Li TC. Reproductive Surgery in Assisted Conception.
Springer, 2015.
O;ice for National Statistics 2019
OAice for National Statistics. Birth characteristics in England
and Wales: 2017. OAice for National Statistics 2019.
Surgical treatment of fibroids for subfertility (Review)









Cochrane Database of Systematic Reviews
Pritts 2009
Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an
updated systematic review of the evidence. Fertility and Sterility
2009;91(4):1215-23.
Sardo 2008
Sardo ADS, Mazzon I, Bramante S, Bettocchi S, Bifulco G,
Guida M. Hysteroscopic myomectomy: a comprehensive
review of surgical techniques. Human Reproduction Update
2008;14:101-19.
Somigliana 2007
Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O,
Crosignani PG. Fibroids and female reproduction: a critical
analysis of the evidence. Human Reproduction Update
2007;13(5):456-76.
Sunkara 2010
Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A.
The eAect of intramural fibroids without uterine cavity
involvement on the outcome of IVF treatment: a
systematic review and meta-analysis. Human Reproduction
2010;25(2):418-29.
Wechter 2011
Wechter M, Stewart E, Myers E, Kho R, Wu J. Leiomyoma-related
hospitalization and surgery: Prevalence and predicted growth
based on population trends. American Journal of Obstetrics and
Gynecology 2011;205:492.e1-492.e5.
Yoshino 2010
Yoshino O, Hayashi T, Osuga Y, Orisaka M, Asada H, Okuda S,
et al. Decreased pregnancy rate is linked to abnormal uterine
peristalsis caused by intramural fibroids. Human Reproduction
2010;25(10):2475-9.
Yoshino 2012
Yoshino O, Nishii O, Osuga Y, Asada H, Okuda S, Orisaka M,
et al. Myomectomy decreases abnormal uterine peristalsis
and increases pregnancy rate. Journal of Minimally Invasive
Gynecology 2012;19(1):63-7.
 
References to other published versions of this review
Gri;iths 2002
GriAiths AN, D'Angelo A, Amso NN. Surgical treatment of fibroids
for subfertility. Cochrane Database of Systematic Reviews 2002,
Issue 3. [DOI: 10.1002/14651858.CD003857]
Gri;iths 2006
GriAiths AN, D'Angelo A, Amso NN. Surgical treatment of fibroids
for subfertility. Cochrane Database of Systematic Reviews 2006,
Issue 3. [DOI: 10.1002/14651858.CD003857.pub2]
Metwally 2012
Metwally M, Cheong YC, Horne AW. Surgical
treatment of fibroids for subfertility. Cochrane
Database of Systematic Reviews 2012, Issue 11. [DOI:
10.1002/14651858.CD003857.pub3]
 
C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Methods Randomised controlled trial
Participants 181 participants
Treatment n = 92, No treatment = 89
Treatment (SM n = 30, IM n = 23, IM/SS n = 17, SM/IM n = 22)
No treatment (SM n = 22, IM n = 22, SS n = 11, IM/SS n = 14, SM/IM n = 20)
Participants woman with infertility and fibroids, with no other cause for infertility.
Inclusion criteria: 1- age: < 35 years; 2- infertility for 1 year or more; 3- presence of one fibroid with max-
imum diameter of 40 mm.
Exclusion criteria: 1- two or more fibroids with diameter more than 40 mm; 2- body weight more than
20% above normal weight; 3- use of medication containing oestrogens, progestins or androgens within
8 weeks prior to starting the study.
Interventions Myomectomy at hysteroscopy or laparotomy or no intervention
Outcomes 1- Clinical pregnancy rate, defined as visualisation of an embryo with cardiac activity at 6–7 weeks of
pregnancy.
2- Miscarriage rate, defined as clinical loss of an intrauterine pregnancy between 7th and 12th weeks of
gestation.
Casini 2006 
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Notes No power calculation
Follow-up period: 12 months
Funding: none stated
Conflict of interest: none stated
Study dates: 1998-2005
Trial registration number: unknown
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation table
Allocation concealment
(selection bias)





Low risk Due to the nature of the intervention, personnel could not be blinded. Further-
more, participants could not be blinded as they either received surgery or did
not. Therefore, performance bias was not considered a source of bias in this
study.
Blinding of outcome as-
sessors (Detection bias) 
All outcomes





Low risk Outcomes reported for all patients who started the study
Selective reporting (re-
porting bias)
Low risk All specified outcomes reported in the results section




Methods Randomised controlled trial
Participants 136 participants
Participants had either symptomatic uterine leiomyomas (n = 74) or infertility (n = 62).
Only unexplained fertility patients were analysed
Laparoscopy n = 30
Laparotomy n = 32
Exclusion criteria: patient characteristics:1- major medical conditions and endocrine diseases, 2- basal
FSH >10 IU/L, 3- psychiatric disorders, 4- current or past history of acute or chronic physical illness, 5-
premenstrual syndrome, 6- current or past (within 6 months) use of hormonal medications, 7- medica-
tions influencing cognition, vigilance, or mood, 8- inability to complete the daily diary, 9- history of al-
cohol abuse, tubal or male factor infertility, 10- no desire to conceive.
Palomba 2007 
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Myoma characteristics: 1- three or more uterine fibroids, 2-fibroids with a main diameter less than 3
cm, 3- fibroids with a mean diameter of more than 10 cm, 4- hypoechoic or calcified fibroids, 5- pres-
ence of submucosal fibroids, 6- uterine cavity distortion diagnosed by hysteroscopy, 7- other uterine or
adnexal abnormalities at ultrasound, 8- endometrial hyperplasia or atypia, 9- abnormal cervical smear.
Interventions Laparoscopic myomectomy or myomectomy by minilaparotomy
Outcomes 1- Cumulative pregnancy rate: calculated as the ratio between number of pregnant women and total
number of patients studied.
2- Cumulative live birth rate: calculated as women with a baby alive over the total number of pregnant
women.
3- Miscarriage rate: defined as the ratio between number of miscarriages during the first 12 weeks of
gestation and total pregnancies.
4- Pregnancy rate and live birth rates per cycle, defined as the ratio between number of pregnancies
and live births, respectively, and the total number of cycles studied.
Notes No power calculation.
Only the subgroup of patients with unexplained infertility were included in the meta-analysis.
Follow-up period: 12 months. Those obtaining pregnancy within 12 months were followed up for an-
other 9 months
Funding: none stated
Conflict of interest: none stated
Study dates: 2002-2003
Trial registration number: unknown
The study was approved by the Institutional Review Board (IRB) of the University “Magna Graecia” of
Catanzaro, Italy
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation performed using online software (www.randomization.it)
Allocation concealment
(selection bias)
Low risk The random allocation sequence was concealed in a closed and dark-coloured





Low risk Due to the nature of the intervention, personnel could not be blinded. Further-
more, participants could not be blinded to which intervention they received as
the surgical incisions varied between interventions. Therefore, performance
bias was not considered a source of bias in this study,
Blinding of outcome as-
sessors (Detection bias) 
All outcomes





Low risk Outcomes reported for all patients who started the study
Palomba 2007  (Continued)
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Selective reporting (re-
porting bias)
Low risk All specified outcomes reported in the results section








Participants infertile women with submucous fibroids
The inclusion criteria were the following: (1) submucous myoma of Type 0 FIGO PALM COEIN classifica-
tion diagnosed during outpatient hysteroscopy, (2) history of infertility, (3) age less than 35 years, (5)
written informed consent, and (6) normal semen parameters of the husband
The exclusion criteria were the following: (1) patients with any other known cause of infertility were ex-
cluded from the study, (2) the presence of fibroid other than Type 0 FIGO PALM COEIN classification, (3)
fibroid size more than 3 cm, or (4) more than 2 myomas
Interventions Hysteroscopic myomectomy using monopolar or bipolar resectoscope
Outcomes Primary outcomes: pregnancy-related indicators (improvement in menstrual symptoms, clinical preg-
nancy rate, abortion rate, live birth rate/ongoing pregnancy rate > 30 weeks)
Secondary outcomes: operative parameters, harmful outcomes related to the procedure, and compari-
son of improvement levels in the menstrual pattern after surgery between the two groups
Notes Authors were contacted regarding gathering data for our primary outcome live birth rate. Live birth rate
is dual reported with ongoing pregnancy rate > 30 weeks in the article. Authors did not respond to our
attempts to contact them.
Power calculation was performed but not adhered to.
Follow-up period: a minimum of 12 months (no average or maximum follow-up period was stated)
Funding: authors state no funding given
Conflict of interest: authors state no conflict of interest
Study dates: 2012-2016
Trial registration number: unknown
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Allocation sequence was concealed and stapled envelopes were handed to the
statistician
Roy 2017 
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Low risk Participants were blinded to which intervention they received. Due to the na-
ture of the intervention, personnel could not be blinded. Therefore, perfor-
mance bias was not considered a source of bias in this study,
Blinding of outcome as-
sessors (Detection bias) 
All outcomes





Low risk Outcomes reported for all participants that started the study
Selective reporting (re-
porting bias)
High risk Four of five prespecified reproductive outcomes were reported on




Methods Randomised controlled trial
Participants 131 participants
Laparoscopy n = 56
Laparotomy n = 59
Participants infertile women with at least one myoma greater than 5 cm.
Inclusion criteria: infertile women with infertility and fibroids.
Exclusion criteria: 1- pedunculated fibroids 2- uterine size above the umbilicus 3-more than three fi-
broids > 5 cm in diameter 4- associated other causes of infertility such as tubal or male factor 5- uterine
cavity abnormalities.
Interventions Laparoscopic myomectomy or myomectomy at laparotomy
Outcomes Surgical outcomes: 1- mean operative time 2- average postoperative drop in haemoglobin 3- Incidence
of postoperative pyrexia 4- average postoperative hospital stay.
Fertility outcomes: 1- clinical pregnancy rate 2- miscarriage rate 3- ongoing clinical pregnancy 4-
preterm delivery rate 5- caesarean section rate.
Notes No power calculation
Follow-up period: authors allowed for 6 months after surgical resection before trying for pregnancy. Af-
ter this, authors state a minimum follow-up period of 12 months. (Group 1 mean: 32.4+/-18.5 months,
Group 2: 30.6+/-16.9 months)
Funding: none stated
Conflict of interest: none stated
Study dates: 1991-1998
Trial registration number: unknown
Seracchioli 2000 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation by random number generation
Allocation concealment
(selection bias)





Low risk Due to the nature of the intervention, personnel could not be blinded. Further-
more, participants could not be blinded as surgical scars varied between inter-
ventions. Therefore, performance bias was not considered a source of bias in
this study,
Blinding of outcome as-
sessors (Detection bias) 
All outcomes





Low risk Outcomes reported for all patients who started the study
Selective reporting (re-
porting bias)
Low risk All specified outcomes reported in the results section
Other bias Low risk No evidence of other bias
Seracchioli 2000  (Continued)
FSH: follicle stimulating hormone; IM: intramural; SM: submucous; SS: subserous.
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Bernard 2000 Retrospective observational study
Bulletti 1999 Prospective observational study
Bulletti 2004 Non randomised study
Campo 2003 Prospective observational study
Chang 2011 1- Non-randomised study
2- Infertility not an inclusion criterion
Chatterjee 2012 Retrospective observational study
Chong 1988 Retrospective observational study
Darai 1997 Retrospective observational study
Dubuisson 2000 Retrospective observational study
Fauconnier 2000 Retrospective observational study
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Study Reason for exclusion
Fernandez 2001 Retrospective observational study
Gatti 1989 Retrospective observational study
Gehlbach 1993 Retrospective observational study
Giatras 1999 Retrospective observational study
Kim 2013 Retrospective observational study
Kramer 2016 Randomised controlled trial but intervention assessed is not within the scope of this review
Li 1999 Retrospective observational study
Litta 2014 Retrospective observational study
Malzoni 2003 Retrospective observational study
Narayan 1994 Retrospective observational study
Ribeiro 1999 Retrospective observational study
Rossetti 2001 Retrospective observational study
Saleh 2018 Prospective observational study
Sato 2018 Conference abstract
Retrospective observational study
Seyam 2015 Prospective controlled study, not randomised
Shokeir 2010 This article was retracted in 2011 by the editors of Fertility and Sterility as it duplicates parts of a
paper in Hum Reprod 2005;20:1632-5
Spies 2010 Prospective study not randomised
Sudik 1996 Comparative retrospective non-randomised study
Ubaldi 1995 Retrospective observational study
Varasteh 1999 Retrospective observational study
Vercellini 1999a Retrospective observational study
Vercellini 1999b Retrospective observational study
Wang 2013 Prospective uncontrolled study
Wang 2016 Retrospective observational study
Wen 2018 Prospective study not randomised
Yarali 2002 Retrospective observational study
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Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Effect of myomectomy for intramural myoma on fertility outcomes in infertile women
Methods Randomised controlled trial
Participants 100 participants (estimated)
Criteria
Inclusion Criteria:
Infertility for at least one year.
Presence of intramural myoma.
Absence of any other cause of infertility as revealed by basic infertility work up including la-
paroscopy.
Exclusion Criteria:
Age is < 20 or > 33 years.
Symptomatic fibroid causing pelviabdominal swelling.
Presence of > 2 myomas.
Presence of a coexisting another type of myoma other than intramural myoma (e.g. submucosal,
subserosal, cervical or ligamentary myoma).
Presence of any other cause of infertility.
Interventions Group 1: Myomectomy by laparotomy
Group 2: Conservative management
Outcomes Primary outcome: Clinical pregnancy rate [Time Frame: 6-8 weeks gestational age] Number of clini-
cal pregnancies (defined as presence of at least one intrauterine gestational sac with fetal pole and
cardiac activity on TVS scan at 6-8 weeks gestational age) divided by the number of women
Secondary outcome: Miscarriage rate [Time Frame: 12 weeks gestational age] Number of first
trimester miscarriages (before 12 weeks gestational age) divided by the number of clinical preg-
nancies
Starting date First posted 8 May 2017
Last updated 30 October 2018
Contact information wrefaie@yahoo.com
Notes https://clinicaltrials.gov/show/NCT03143114




Trial name or title Does myomectomy for intramural fibroid improve ART outcome?
NCT03796130 
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Methods Randomised controlled trial
Participants 80 participants (estimated)
This study will include women who have intramural myomas ranging from 3-5 cm
Interventions Group 1: Myomectomy will be performed before ART
Group 2: Women will have their trial of ART without myomectomy
Outcomes Primary outcome: Ongoing pregnancy rate [Time Frame: 3 months after embryo transfer]
Secondary outcomes:
1. Implantation rate [Time Frame: 15 days after embryo transfer]




Authors were contacted regarding preliminary data but no response was received
NCT03796130  (Continued)
ART: assisted reproductive technology
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Myomectomy versus no intervention





Statistical method Effect size
1 Clinical pregnancy rate 1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Intramural 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Submucous 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Intramural/Subserous 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Intramural/Submucous 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Miscarriage rate 1   Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Intramural 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Submucous 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Intramural/Subserous 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 Intramural/Submucous 1   Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1.   Comparison 1 Myomectomy versus no intervention, Outcome 1 Clinical pregnancy rate.
Study or subgroup Myomectomy No intervention Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
1.1.1 Intramural  
Casini 2006 13/23 9/22 1.88[0.57,6.14]
   
1.1.2 Submucous  
Casini 2006 13/30 6/22 2.04[0.62,6.66]
   
1.1.3 Intramural/Subserous  
Casini 2006 6/17 3/14 2[0.4,10.09]
   
1.1.4 Intramural/Submucous  
Casini 2006 8/22 3/20 3.24[0.72,14.57]
Favours no intervention 1000.01 100.1 1 Favours myomectomy
 
 
Analysis 1.2.   Comparison 1 Myomectomy versus no intervention, Outcome 2 Miscarriage rate.
Study or subgroup Myomectomy No intervention Odds Ratio Odds Ratio
  n/N n/N M-H, Fixed, 95% CI M-H, Fixed, 95% CI
1.2.1 Intramural  
Casini 2006 4/23 3/22 1.33[0.26,6.78]
   
1.2.2 Submucous  
Casini 2006 5/30 3/22 1.27[0.27,5.97]
   
1.2.3 Intramural/Subserous  
Casini 2006 2/17 2/14 0.8[0.1,6.54]
   
1.2.4 Intramural/Submucous  
Casini 2006 4/22 2/20 2[0.32,12.33]
Myomectomy 1000.01 100.1 1 No intervention
 
 
Comparison 2.   Laparoscopic myomectomy versus myomectomy by laparotomy or mini laparotomy





Statistical method Effect size
1 Live birth rate 2 177 Odds Ratio (M-H, Fixed, 95% CI) 0.80 [0.42, 1.50]
2 Preterm delivery rate 2 177 Odds Ratio (M-H, Fixed, 95% CI) 0.70 [0.11, 4.29]
3 Clinical pregnancy rate 2 177 Odds Ratio (M-H, Fixed, 95% CI) 0.96 [0.52, 1.78]
4 Ongoing pregnancy rate 1 115 Odds Ratio (M-H, Fixed, 95% CI) 1.61 [0.26, 10.04]
5 Miscarriage rate 2 177 Odds Ratio (M-H, Fixed, 95% CI) 1.25 [0.40, 3.89]
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Statistical method Effect size
6 Caesarean section rate 2 177 Odds Ratio (M-H, Fixed, 95% CI) 0.69 [0.34, 1.39]
 
 
Analysis 2.1.   Comparison 2 Laparoscopic myomectomy versus
myomectomy by laparotomy or mini laparotomy, Outcome 1 Live birth rate.
Study or subgroup Laparoscopy Laparotomy Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Palomba 2007 7/30 6/32 20.84% 1.32[0.39,4.5]
Seracchioli 2000 20/56 27/59 79.16% 0.66[0.31,1.39]
   
Total (95% CI) 86 91 100% 0.8[0.42,1.5]
Total events: 27 (Laparoscopy), 33 (Laparotomy)  
Heterogeneity: Tau2=0; Chi2=0.9, df=1(P=0.34); I2=0%  
Test for overall effect: Z=0.7(P=0.48)  
Favours laparotomy 100.1 50.2 20.5 1 Favours laparoscopy
 
 
Analysis 2.2.   Comparison 2 Laparoscopic myomectomy versus myomectomy
by laparotomy or mini laparotomy, Outcome 2 Preterm delivery rate.
Study or subgroup Favours la-
paroscopy
Laparotomy Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Palomba 2007 1/30 1/32 32.84% 1.07[0.06,17.89]
Seracchioli 2000 1/56 2/59 67.16% 0.52[0.05,5.88]
   
Total (95% CI) 86 91 100% 0.7[0.11,4.29]
Total events: 2 (Favours laparoscopy), 3 (Laparotomy)  
Heterogeneity: Tau2=0; Chi2=0.15, df=1(P=0.7); I2=0%  
Test for overall effect: Z=0.39(P=0.7)  
Favours laparoscopy 1000.01 100.1 1 Favours laparotomy
 
 
Analysis 2.3.   Comparison 2 Laparoscopic myomectomy versus myomectomy
by laparotomy or mini laparotomy, Outcome 3 Clinical pregnancy rate.
Study or subgroup Laparoscopy Laparotomy Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Palomba 2007 8/30 8/32 27.56% 1.09[0.35,3.4]
Seracchioli 2000 30/56 33/59 72.44% 0.91[0.44,1.9]
   
Total (95% CI) 86 91 100% 0.96[0.52,1.78]
Total events: 38 (Laparoscopy), 41 (Laparotomy)  
Heterogeneity: Tau2=0; Chi2=0.07, df=1(P=0.79); I2=0%  
Test for overall effect: Z=0.13(P=0.89)  
Favours laparotomy 100.1 50.2 20.5 1 Favours laparoscopy
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Analysis 2.4.   Comparison 2 Laparoscopic myomectomy versus myomectomy
by laparotomy or mini laparotomy, Outcome 4 Ongoing pregnancy rate.
Study or subgroup Laparoscopy Laparotomy Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Seracchioli 2000 3/56 2/59 100% 1.61[0.26,10.04]
   
Total (95% CI) 56 59 100% 1.61[0.26,10.04]
Total events: 3 (Laparoscopy), 2 (Laparotomy)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.51(P=0.61)  
Favours laparotomy 1000.01 100.1 1 Favours laparoscopy
 
 
Analysis 2.5.   Comparison 2 Laparoscopic myomectomy versus myomectomy
by laparotomy or mini laparotomy, Outcome 5 Miscarriage rate.
Study or subgroup Laparoscopy Laparotomy Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Palomba 2007 1/30 2/32 34.98% 0.52[0.04,6.02]
Seracchioli 2000 6/56 4/59 65.02% 1.65[0.44,6.19]
   
Total (95% CI) 86 91 100% 1.25[0.4,3.89]
Total events: 7 (Laparoscopy), 6 (Laparotomy)  
Heterogeneity: Tau2=0; Chi2=0.67, df=1(P=0.41); I2=0%  
Test for overall effect: Z=0.39(P=0.7)  
Favours laparoscopy 1000.01 100.1 1 Favours laparotomy
 
 
Analysis 2.6.   Comparison 2 Laparoscopic myomectomy versus myomectomy
by laparotomy or mini laparotomy, Outcome 6 Caesarean section rate.
Study or subgroup Laparoscopy Laparotomy Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Palomba 2007 5/30 4/32 17.04% 1.4[0.34,5.8]
Seracchioli 2000 13/56 21/59 82.96% 0.55[0.24,1.24]
   
Total (95% CI) 86 91 100% 0.69[0.34,1.39]
Total events: 18 (Laparoscopy), 25 (Laparotomy)  
Heterogeneity: Tau2=0; Chi2=1.26, df=1(P=0.26); I2=20.74%  
Test for overall effect: Z=1.03(P=0.3)  
Favours laparoscopy 1000.01 100.1 1 Favours laparotomy
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Comparison 3.   Monopolar versus bipolar resectoscope use in hysteroscopic myomectomy





Statistical method Effect size
1 Live birth rate/ongoing pregnancy rate 1 68 Odds Ratio (M-H, Fixed, 95% CI) 0.86 [0.30, 2.50]
2 Clinical pregnancy rate 1 68 Odds Ratio (M-H, Fixed, 95% CI) 0.88 [0.33, 2.36]
3 Miscarriage rate 1 68 Odds Ratio (M-H, Fixed, 95% CI) 1.0 [0.19, 5.34]
 
 
Analysis 3.1.   Comparison 3 Monopolar versus bipolar resectoscope use in
hysteroscopic myomectomy, Outcome 1 Live birth rate/ongoing pregnancy rate.




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Roy 2017 9/34 10/34 100% 0.86[0.3,2.5]
   
Total (95% CI) 34 34 100% 0.86[0.3,2.5]
Total events: 9 (Monopolar resectoscope), 10 (Bipolar resectoscope)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.27(P=0.79)  
Favours bipolar 1000.01 100.1 1 Favours monopolar
 
 
Analysis 3.2.   Comparison 3 Monopolar versus bipolar resectoscope
use in hysteroscopic myomectomy, Outcome 2 Clinical pregnancy rate.




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Roy 2017 12/34 13/34 100% 0.88[0.33,2.36]
   
Total (95% CI) 34 34 100% 0.88[0.33,2.36]
Total events: 12 (Monopolar resectoscope), 13 (Bipolar resectoscope)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.25(P=0.8)  
Favours bipolar 1000.01 100.1 1 Favours monopolar
 
 
Analysis 3.3.   Comparison 3 Monopolar versus bipolar resectoscope
use in hysteroscopic myomectomy, Outcome 3 Miscarriage rate.




Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Roy 2017 3/34 3/34 100% 1[0.19,5.34]
   
Favours monopolar 1000.01 100.1 1 Favours bipolar
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Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 34 34 100% 1[0.19,5.34]
Total events: 3 (Monopolar resectoscope), 3 (Bipolar resectoscope)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours monopolar 1000.01 100.1 1 Favours bipolar
 
 
A P P E N D I C E S
Appendix 1. Cochrane Gynaecology and Fertility Group's specialised register search strategy
Searched 26 February 2019
Procite platform
Keywords CONTAINS "fibroid" or "Leiomyoma*" or "myoma" or "myomas" or "uterine leiomyomas" or "uterine myoma" or "uterine
myomas" or "uterine fibroids" or "fibroids" or Title CONTAINS "fibroid" or "Leiomyoma*" or "myoma" or "myomas" or "uterine
leiomyomas" or "uterine myoma" or "uterine myomas" or "uterine fibroids" or "fibroids"
AND
Keywords CONTAINS "surgery" or "surgery-gynaecological" or "surgery vs medicine" or "Surgical" or "*Surgical-Procedures,-
Laparoscopic" or "surgical treatment" or "myomectomy" or "laparoscopic myomectomy" or "laparoscopic procedure" or "laparoscopic
   surgical treatment" or "laparotomy" or "hysteroscopic surgery" or "hysteroscopy" or "microlaparoscopy" or "microsurgery" or Title
CONTAINS   "surgery" or "surgery-gynaecological" or "surgery vs medicine" or "Surgical" or "*Surgical-Procedures,-Laparoscopic" or
"surgical treatment" or "myomectomy" or "laparoscopic myomectomy" or "laparoscopic procedure" or "laparoscopic  surgical treatment"
or "laparotomy" or "hysteroscopic surgery" or "hysteroscopy" or "microlaparoscopy" or "microsurgery"
(408 records)
Appendix 2. CENTRAL via Cochrane Central Register of Studies Online (CRSO) search strategy
Searched 26 February 2019
Web platform
#1 MESH DESCRIPTOR Leiomyoma EXPLODE ALL TREES 584
#2 MESH DESCRIPTOR Myoma EXPLODE ALL TREES 24
#3 (Leiomyoma* or fibroid*):TI,AB,KY 1091
#4 (uter* adj5 fibroma*):TI,AB,KY 13
#5 (myom* or hysteromyom* or fibromyom*):TI,AB,KY 1560
#6 #1 OR #2 OR #3 OR #4 OR #5 2125
#7 MESH DESCRIPTOR Gynecologic Surgical Procedures EXPLODE ALL TREES 4028
#8 MESH DESCRIPTOR Laparoscopy EXPLODE ALL TREES 5124
#9 MESH DESCRIPTOR Hysteroscopy EXPLODE ALL TREES 363
#10 MESH DESCRIPTOR Uterine Myomectomy EXPLODE ALL TREES 46
#11 MESH DESCRIPTOR Microsurgery EXPLODE ALL TREES 614
#12 MESH DESCRIPTOR Laparotomy EXPLODE ALL TREES 701
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#13 (microsurg* or surg*):TI,AB,KY 173032
#14 (Laparoscop* or minilaparoscop*):TI,AB,KY 13570
#15 Hysteroscop* :TI,AB,KY 1037
#16 myomectom*:TI,AB,KY 535
#17 (Laparotom* or minilaparotom*):TI,AB,KY 2489
#18 #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 177578
#19 #6 AND #18 1158
#20 2012 TO 2019:YR 514326
#21 01/01/2012 TO 26/02/2019:CD 643072
#22 #20 OR #21 643083
#23 #19 AND #22 673
Appendix 3. MEDLINE search strategy
Searched from 1946 to 26 February 2019
OVID platform
1. exp Leiomyoma/ (20114)
2. (Leiomyoma$ or fibroid$).tw. (18116)
3. (uter$ adj5 fibroma$).tw. (405)
4. exp Myoma/ (2716)
5. (myom$ or hysteromyom$ or fibromyom$).tw. (23071)
6. or/1-5 (44362)
7. exp Gynecologic Surgical Procedures/ (78898)
8. microsurg$.tw. (23975)
9. exp hysteroscopy/ or exp laparoscopy/ (94599)
10. exp Uterine Myomectomy/ (742)
11. exp Microsurgery/ (32013)
12. exp Laparotomy/ (18164)







20. 6 and 19 (14784)
21. randomized controlled trial.pt. (476544)
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22. controlled clinical trial.pt. (92921)
23. randomized.ab. (435206)
24. placebo.tw. (200882)
25. clinical trials as topic.sh. (186073)
26. randomly.ab. (305887)
27. trial.ti. (194540)
28. (crossover or cross-over or cross over).tw. (79266)
29. or/21-28 (1227748)
30. exp animals/ not humans.sh. (4549808)
31. 29 not 30 (1127992)
32. 20 and 31 (873)
Appendix 4. Embase search strategy
Searched from 1980 to 26 February 2019
OVID platform
1. exp leiomyoma/ or exp uterus myoma/ (29328)
2. (Leiomyoma$ or fibroid$).tw. (24016)
3. (uter$ adj5 fibroma$).tw. (345)
4. (myom$ or hysteromyom$ or fibromyom$).tw. (28853)
5. or/1-4 (54814)
6. exp Gynecologic Surgical Procedures/ or exp uterus surgery/ (134198)
7. microsurg$.tw. (27861)
8. exp microsurgery/ or exp myotomy/ (37988)
9. exp Laparotomy/ (70673)
10. (Laparoscop$ or minilaparoscop$).tw. (184220)
11. exp Laparoscopy/ (146549)
12. Hysteroscop$.tw. (10932)
13. exp hysteroscopy/ (11137)
14. surg$.tw. (2244163)





20. Clinical Trial/ (944597)
21. Randomized Controlled Trial/ (533054)
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22. exp randomization/ (81333)
23. Single Blind Procedure/ (33971)
24. Double Blind Procedure/ (155315)
25. Crossover Procedure/ (58216)
26. Placebo/ (316874)
27. Randomi?ed controlled trial$.tw. (197224)
28. Rct.tw. (31346)
29. random allocation.tw. (1859)
30. randomly allocated.tw. (31715)
31. allocated randomly.tw. (2398)
32. (allocated adj2 random).tw. (799)
33. Single blind$.tw. (22115)
34. Double blind$.tw. (188192)
35. ((treble or triple) adj blind$).tw. (902)
36. placebo$.tw. (279419)
37. prospective study/ (501549)
38. or/20-37 (1982692)
39. case study/ (59090)
40. case report.tw. (363254)
41. abstract report/ or letter/ (1049465)
42. or/39-41 (1462477)
43. 38 not 42 (1932607)
44. 5 and 19 and 43 (2735)
Appendix 5. PsycINFO search strategy
Searched from 1806 to 26 February 2019
OVID platform
1. (Leiomyoma$ or fibroid$).tw. (77)
2. (uter$ adj5 fibroma$).tw. (4)
3. (myoma$ or hysteromyoma$ or fibromyom$).tw. (29)
4. or/1-3 (109)
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17. clinical trials/ (11241)
18. placebo/ (5205)
19. exp Treatment/ (725477)
20. or/14-19 (1134175)
21. 13 and 20 (31)
Appendix 6. CINAHL search strategy




S32 S19 AND S31 322
S31 S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 1,304,565
S30 TX allocat* random* 9,874
S29 (MH "Quantitative Studies") 21,853
S28 (MH "Placebos") 11,144
S27 TX placebo* 55,420
S26 TX random* allocat* 9,874
S25 (MH "Random Assignment") 53,511
S24 TX randomi* control* trial* 163,780
S23 TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1
mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1
mask*) )
1,003,357
S22 TX clinic* n1 trial* 238,860
S21 PT Clinical trial 86,752
S20 (MH "Clinical Trials+") 254,336
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S19 S6 AND S18 2,222
S18 S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 47,294
S17 TX minilaparotom* 116
S16 TX Laparotom* 6,681
S15 TX myomectom* 1,051
S14 (MM "Surgery, Laparoscopic+") 4,407
S13 TX Hysteroscop* 2,058
S12 (MM "Hysteroscopy") 872
S11 TX Laparoscop* or TX minilaparoscop* 30,260
S10 (MM "Laparotomy") 1,092
S9 (MM "Microsurgery+") 1,614
S8 TX microsurg* 3,913
S7 (MM "Surgery, Gynecologic+") 8,805
S6 S1 OR S2 OR S3 OR S4 OR S5 6,654
S5 TX myom* or TX hysteromyom* or TX fibromyom* 2,989
S4 (MM "Myoma+") 213
S3 TX uter* N5 fibroma* 21
S2 TX Leiomyoma* or TX fibroid* 4,606
S1 (MM "Leiomyoma") 2,684
  (Continued)
 
Appendix 7. Data extraction form
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Location  
Study design  





Risk of bias  
  (Continued)
 
W H A T ' S   N E W
 
Date Event Description
6 June 2019 New citation required but conclusions
have not changed
The addition of one new included study has not changed the
conclusions of this review.
6 June 2019 New search has been performed New study included: Roy 2017
Eleven studies excluded: Spies 2010; Chatterjee 2012; Kim 2013;
Wang 2013; Litta 2014; Seyam 2015; Kramer 2016; Wang 2016;
Saleh 2018; Sato 2018; Wen 2018;
Two ongoing clinical trials NCT03143114; NCT03796130.
Primary and secondary outcome measures have been updated
and modified. Live birth rate remained the primary effectiveness
measure. Preterm delivery was promoted to a primary outcome
as the primary safety measure as it is the leading cause of neona-
tal mortality.
Methods sections updated to reflect CGF policy e.g. ensuring the
denominator for the primary analyses is per woman randomised.
 
H I S T O R Y
Protocol first published: Issue 4, 2002
Review first published: Issue 3, 2006
 
Date Event Description
12 September 2012 New citation required but conclusions
have not changed
There remains insufficient evidence for performing myomecto-
my to improve fertility.
29 August 2012 New search has been performed Summary of findings tables generated from GRADE software and
incorporated in review.
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Date Event Description
2 new studies included: Casini 2006; Palomba 2007; 3 studies
excluded: Bulletti 2004; Chang 2011; Shokeir 2010. Primary and
secondary outcome measures have been updated and modified.
The primary outcome measure is live birth rate, while secondary
outcomes include: ongoing pregnancy rate, miscarriage rate,
clinical pregnancy rate, caesarean section and preterm delivery
rates.
17 November 2010 New search has been performed Updated searches performed
6 November 2008 Amended Converted to new review format.
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
Primary and secondary outcome measures have been updated and modified. In the previous review, only one primary outcome existed
(Primary eAectiveness measure: Live birth rate). Preterm delivery rate was promoted from a secondary outcome to a primary outcome
as the primary safety measure as it is the leading cause of neonatal mortality. Secondary outcomes are clinical pregnancy rate, ongoing
pregnancy rate, miscarriage rate, clinical pregnancy rate and caesarean section. Methods sections have been updated to reflect Cochrane
Gynaecology and Fertility policy such as ensuring the denominator for the primary analyses is per woman randomised.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
Abortion, Spontaneous  [epidemiology];  Cesarean Section  [statistics & numerical data];  Infertility, Female  [etiology]  [*surgery]; 
Leiomyomatosis  [complications]  [*surgery];  Live Birth  [epidemiology];  Pregnancy Rate;  Randomized Controlled Trials as Topic; 
Uterine Myomectomy  [*methods];  Uterine Neoplasms  [complications]  [*surgery]
MeSH check words
Female; Humans; Pregnancy
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